Hamartoma Syndrome, Multiple
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
4
|
|
1.000 |
None |
0.961 |
70 |
89
|
1972 |
2019 |
Lhermitte-Duclos disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
3
|
|
1.000 |
limited |
0.981 |
30 |
56
|
1975 |
2019 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
105
|
|
1.000 |
strong |
0.975 |
0 |
5
|
1972 |
2020 |
MACROCEPHALY/AUTISM SYNDROME
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
1
|
|
0.910 |
None |
1.000 |
19 |
21
|
1972 |
2019 |
PTEN Hamartoma Tumor Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
3
|
|
0.800 |
definitive |
1.000 |
125 |
191
|
1972 |
2020 |
Squamous cell carcinoma of the head and neck
|
disease |
Neoplasms
|
Neoplastic Process
|
27
|
|
0.800 |
strong |
0.952 |
1 |
3
|
1972 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
108
|
|
0.800 |
strong |
0.956 |
0 |
1
|
1997 |
2020 |
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
103
|
|
0.800 |
strong |
0.950 |
0 |
3
|
1997 |
2020 |
Endometrial Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
55
|
|
0.800 |
strong |
0.978 |
0 |
4
|
1972 |
2019 |
Proteus-Like Syndrome (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Musculoskeletal Diseases
|
Disease or Syndrome
|
3
|
|
0.740 |
strong |
1.000 |
30 |
54
|
1975 |
2017 |
ovarian neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
119
|
|
0.700 |
None |
1.000 |
3 |
21
|
1997 |
2019 |
Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
78
|
|
0.700 |
None |
1.000 |
1 |
2
|
1998 |
2020 |
Bannayan-Riley-Ruvalcaba Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Disease or Syndrome
|
1
|
|
0.700 |
None |
0.967 |
0 |
1
|
1997 |
2019 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
36
|
|
0.700 |
None |
1.000 |
0 |
|
1997 |
2019 |
Lung Neoplasms
|
group |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
27
|
|
0.700 |
None |
1.000 |
0 |
|
1998 |
2017 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
377
|
|
0.700 |
None |
0.966 |
0 |
1
|
1997 |
2020 |
VACTERL Association With Hydrocephalus
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Musculoskeletal Diseases; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
2
|
|
0.610 |
None |
1.000 |
5 |
5
|
1972 |
2017 |
GLIOMA SUSCEPTIBILITY 2
|
disease |
|
Finding
|
1
|
|
0.600 |
strong |
1.000 |
0 |
5
|
1972 |
2002 |
Non-Small Cell Lung Carcinoma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
38
|
|
0.500 |
None |
1.000 |
7 |
1
|
1998 |
2020 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
48
|
|
0.500 |
None |
1.000 |
5 |
6
|
1998 |
2019 |
Brain Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
17
|
|
0.500 |
None |
1.000 |
3 |
4
|
1999 |
2017 |
Autistic Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
244
|
|
0.500 |
None |
1.000 |
2 |
2
|
2001 |
2020 |
Small cell carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
17
|
|
0.500 |
None |
0.923 |
1 |
2
|
1998 |
2019 |
Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
33
|
|
0.500 |
None |
0.977 |
1 |
2
|
1997 |
2020 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
15
|
|
0.500 |
None |
0.867 |
0 |
|
1997 |
2019 |